Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A T Van Oosterom

Showing results (1-10 of 253) with videos related to

Pageof 26
Sort By:
Seminars in Oncology|December 1, 1995
Docetaxel (Taxotere): an effective agent in the management of second-line breast cancerA T van Oosterom
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1992
The treatment of high-volume testicular cancer: a persisting dilemmaA T van Oosterom
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1990
Surgery for lung metastases of sarcomasA T van Oosterom
Seminars in Oncology|August 7, 1999
Docetaxel (Taxotere) and gemcitabine phase I and early phase II studies: results to date and an overview of ongoing studiesA T van Oosterom
Hematology/Oncology Clinics of North America|August 1, 1995
New drugs for the treatment of sarcomasA T van Oosterom, J Verweij
Journal Belge De Radiologie|August 1, 1992
The multidisciplinary approach to treatment of soft tissue sarcomasJ Verweij, A T van Oosterom
European Journal of Cancer (Oxford, England : 1990)|February 23, 2002
40 years of the EORTC: the evolution towards a unique network to develop new standards of cancer care. European Organisation for Research and Treatment of CancerF Meunier, A T van Oosterom
Nederlands Tijdschrift Voor Geneeskunde|December 19, 1981
[Various late-occurring side effects of cytostatic agents]R Somers, A T van Oosterom
Anti-Cancer Drugs|January 12, 2000
Irinotecan in cancers of the lung and cervixA Sandler, A T van Oosterom
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Recent developments in the biology and management of advanced bladder cancerA T van Oosterom, D Schrijvers
Pageof 26

Showing results (1-10 of 253) with videos related to

Sort By:
Pageof 26
Seminars in Oncology|December 1, 1995
Docetaxel (Taxotere): an effective agent in the management of second-line breast cancerA T van Oosterom
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1992
The treatment of high-volume testicular cancer: a persisting dilemmaA T van Oosterom
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1990
Surgery for lung metastases of sarcomasA T van Oosterom
Seminars in Oncology|August 7, 1999
Docetaxel (Taxotere) and gemcitabine phase I and early phase II studies: results to date and an overview of ongoing studiesA T van Oosterom
Hematology/Oncology Clinics of North America|August 1, 1995
New drugs for the treatment of sarcomasA T van Oosterom, J Verweij
Journal Belge De Radiologie|August 1, 1992
The multidisciplinary approach to treatment of soft tissue sarcomasJ Verweij, A T van Oosterom
European Journal of Cancer (Oxford, England : 1990)|February 23, 2002
40 years of the EORTC: the evolution towards a unique network to develop new standards of cancer care. European Organisation for Research and Treatment of CancerF Meunier, A T van Oosterom
Nederlands Tijdschrift Voor Geneeskunde|December 19, 1981
[Various late-occurring side effects of cytostatic agents]R Somers, A T van Oosterom
Anti-Cancer Drugs|January 12, 2000
Irinotecan in cancers of the lung and cervixA Sandler, A T van Oosterom
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Recent developments in the biology and management of advanced bladder cancerA T van Oosterom, D Schrijvers
Pageof 26